Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Pathogenetic relevance of HLA class II expressing thyroid follicular cells in nontoxic Goiter and in Graves' disease.
B Grubeck-Loebenstein, … , W Waldhäusl, M Feldmann
B Grubeck-Loebenstein, … , W Waldhäusl, M Feldmann
Published May 1, 1988
Citation Information: J Clin Invest. 1988;81(5):1608-1614. https://doi.org/10.1172/JCI113495.
View: Text | PDF
Research Article

Pathogenetic relevance of HLA class II expressing thyroid follicular cells in nontoxic Goiter and in Graves' disease.

  • Text
  • PDF
Abstract

HLA class II expressing thyroid follicular cells are found not only in classical thyroid autoimmune diseases, such as Graves' disease, but also in presumably nonautoimmune thyroid disorders such as nontoxic goiter. In this study the immunostimulatory function of the HLA class II expressing thyroid follicular cells derived from patients with nontoxic goiter and with Graves' disease was compared by assessing their capacity to stimulate allogeneic and autologous peripheral blood mononuclear cells, as well as cultured intrathyriodal T lymphocytes. Proliferation of allogeneic peripheral blood mononuclear cells was stimulated by thyroid follicular cells from both nontoxic goiter and Graves' disease thyroids, thus demonstrating that thyroid follicular cells from both disorders are capable of presenting alloantigens. In contrast the proliferation of autologous peripheral blood mononuclear cells was more efficiently stimulated by thyroid follicular cells from Graves' disease than from nontoxic goiter. Cultured intrathyroidal T lymphocytes proliferated specifically in response to autologous HLA class II+ thyroid follicular cells in Graves' disease, but not in nontoxic goiter. The responses were dose dependent and HLA class II restricted. Thyroid autoantigen presentation by HLA class II expressing thyroid follicular cells thus only occurs in Graves' disease, suggesting that HLA class II expression on thyroid follicular cells is an essential feature, but by itself not sufficient for the induction of autoimmunity. Additional factors, the possible nature of which is discussed must also be involved.

Authors

B Grubeck-Loebenstein, M Londei, C Greenall, K Pirich, H Kassal, W Waldhäusl, M Feldmann

×

Total citations by year

Year: 2001 2000 1999 1998 1997 1995 1994 1992 1991 1990 1989 Total
Citations: 1 1 3 4 2 1 3 6 5 3 7 36
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (36)

Title and authors Publication Year
Antithyroid Drugs InhibitIn VivoHLA-DR Expression in Thyroid Follicular Cells in Graves' Disease
DE Zantut-Wittmann, MA Tambascia, MA da Trevisan, GA Pinto, J Vassallo
Thyroid 2001
Graves’ Disease
B Rapoport, SM McLachlan
2000
Suppressive effects of anti-inflammatory agents on human endothelial cell activation and induction of heat shock proteins
A Amberger, M Hala, M Saurwein-Teissl, B Metzler, B Grubeck-Loebenstein, Q Xu, G Wick
Molecular Medicine 1999
Autoimmune and non-autoimmune thyroid diseases have different patterns of cellular HLA class II expression
DE Zantut-Wittmann, LH Boechat, GA Pinto, MA da Trevisan, J Vassallo
Sao Paulo Medical Journal 1999
Suppressive Effects of Anti-inflammatory Agents on Human Endothelial Cell Activation and Induction of Heat Shock Proteins
A Amberger, M Hala, M Saurwein-Teissl, B Metzler, B Grubeck-Loebenstein, Q Xu, G Wick
Molecular Medicine 1999
Influenza vaccination in a healthy geriatric population: preferential induction of antibodies specific for the H3N2 influenza strain despite equal T cell responsiveness to all vaccine strains
M Saurwein-Teissl, MM Steger, R Glück, S Cryz, B Grubeck-Loebenstein
Vaccine 1998
Human leukocyte antigens associated with hyperthyroid graves ophthalmopathy in japanese patients
K Ohtsuka, Y Nakamura
American Journal of Ophthalmology 1998
The Thyrotropin (TSH)-Releasing Hormone Receptor: Interaction with TSH and Autoantibodies 1
B Rapoport, GD Chazenbalk, JC Jaume, SM McLachlan
Endocrine reviews 1998
The possible role of the immune system in Alzheimer’s disease
F Marx, I Blasko, M Pavelka, B Grubeck-Loebenstein
Experimental Gerontology 1998
Primary and secondary alterations of immune reactivity in the elderly: impact of dietary factors and disease
G Wick, B Grubeck-Loebenstein
Immunological Reviews 1997
Antigen presentation by interferon-γ-treated thyroid follicular cells inhibits interleukin-2 (IL-2) and supports IL-4 production by B7-dependent human T cells
G Lombardi, K Arnold, J Uren, F Marelli-Berg, R Hargreaves, N Imami, A Weetman, R Lechler
European Journal of Immunology 1997
Identification of thyroid stimulating hormone receptor-specific T cells in Graves' disease thyroid using autoantigen-transfected Epstein-Barr virus-transformed B cell lines
RJ Mullins, SB Cohen, LM Webb, Y Chernajovsky, CM Dayan, M Londei, M Feldmann
Journal of Clinical Investigation 1995
Retrobulbar T cells from patients with Graves' ophthalmopathy are CD8+ and specifically recognize autologous fibroblasts
B Grubeck-Loebenstein, K Trieb, A Sztankay, W Holter, H Anderl, G Wick
Journal of Clinical Investigation 1994
Immunoglobujin A in Graves’ orbital tissue: Deoxyribonucleic acid amplification by polymerase chain reaction
SM McLachlan, MF Prummel, JC Jaume, B Rapoport
Journal of Endocrinological Investigation 1994
Effects of type I-interferons on human thyroid epithelial cells derived from normal and tumour tissue
E Selzer, A Wilfing, V Sexl, M Freissmuth
Naunyn-Schmiedeberg's Archives of Pharmacology 1994
HLA-DR expression by platelets in acute idiopathic thrombocytopenic purpura
LK Boshkov, JG Kelton, PF Halloran
British Journal of Haematology 1992
AUTOIMMUNE THYROIDITIS AND TARGETED ANTI-T CELL IMMUNOTHERAPY IN MAN
CM Dayan, M Feldmann, B Rapoport, M Londei
Autoimmunity 1992
T cell activation and antigen presentation inhuman thyroid autoimmunity
M Feldmann, C Dayan, B Rapoport, M Londei
Journal of Autoimmunity 1992
Expression of intercellular adhesion molecule-1 in thyroid follicular cells in autoimmune, non-autoimmune and neoplastic diseases of the thyroid gland: Discordance with HLA
E Tolosa, C Roura, M Catálfamo, M Martí, A Lucas-Martín, A Sanmartí, I Salinas, G Obiols, M Foz-Sala, R Pujol-Borrell
Journal of Autoimmunity 1992
Mechanism of Graves Thyroiditis: Implications for Concepts and Therapy of Autoimmunity
M Feldmann, C Dayan, B Grubeck-loebenstein, B Rapoport, M Londei
International Reviews of Immunology 1992
Epithelial cells bearing class II molecules stimulate allogeneic human colonic intraepithelial lymphocytes
P Hoang, B Crotty, HR Dalton, DP Jewell
Gut 1992
Autoantigen recognition by thyroid-infiltrating T cells in Graves disease
CM Dayan, M Londei, AE Corcoran, B Grubeck-Loebenstein, RF James, B Rapoport, M Feldmann
Proceedings of the National Academy of Sciences 1991
Detection of interleukin-6 and interleukin-1 production in human thyroid epithelial cells by non-radioactive in situ hybridization and immunohistochemical methods
RQ Zheng, E Abney, CQ Chu, M Field, B Grubeck-Loebenstein, RN Maini, M Feldmann
Clinical & Experimental Immunology 1991
The immunoregulatory influence of transforming growth factor beta in thyroid autoimmunity: TGF β inhibits autoreactivity in Graves' disease
J Widder, K Dorfinger, A Wilfing, K Trieb, K Pirich, R Loebenstein, B Niederle, A Gessl, S Spitzauer, B Grubeck-Loebenstein
Journal of Autoimmunity 1991
Advances in Molecular Biology: Potential Impact on Diagnosis and Treatment of Disorders of the Thyroid
JD Baxter
Medical Clinics of North America 1991
Autoimmune Thyroiditis
WA Scherbaum, U Bogner, B Weinheimer, GF Bottazzo
1991
CD4+ T-Cell Clones from Autoimmune Thyroid Tissue Cannot be Classified According to their Lymphokine Production
B Grubeck-Loebenstein, M Turner, K Pirich, H Kassal, M Londei, W Waldhausl, M Feldmann
Scandinavian Journal of Immunology 1990
T-Cell Recognition of HLA Class II Molecules Induced by Gamma-Interferon on a Colonic Adenocarcinoma Cell Line (HT29)
KE Lundin, LM Sollid, V Bosnes, G Gaudernack, E Thorsby
Scandinavian Journal of Immunology 1990
The Role of Micro-organisms in Non-infectious Diseases
RR de Vries, IR Cohen, JJ van Rood
1990
Transforming growth factor beta regulates thyroid growth. Role in the pathogenesis of nontoxic goiter
B Grubeck-Loebenstein, G Buchan, R Sadeghi, M Kissonerghis, M Londei, M Turner, K Pirich, R Roka, B Niederle, H Kassal
Journal of Clinical Investigation 1989
Analysis of intrathyroidal cytokine production in thyroid autoimmune disease: thyroid follicular cells produce interleukin-1 alpha and interleukin-6
B Grubeck-Loebenstein, G Buchan, D Chantry, H Kassal, M Londei, K Pirich, K Barrett, M Turner, W Waldhausl, M Feldmann
Clinical & Experimental Immunology 1989
Analysis of T-cell receptor usage in activated T-cell clones from Hashimoto's thyroiditis and Graves' disease
M Lipoldova, M Londei, B Grubeck-Loebenstein, M Feldmann, MJ Owen
Journal of Autoimmunity 1989
Tumour Necrosis Factor Synergises with Gamma Interferon on the Induction of mRNA for DR Alpha Chain on Thyrocytes from Graves' Disease and Non Toxic Goitre
AM Kissonerghis, B Grubeck-Loebenstein, K Pirich, M Feldmann, M Londei
Autoimmunity 1989
Intrathyroidal cytokine production in thyroid disease
B Grubeck-Loebenstein, G Buchan, D Chantry, M Turner, M Londei, M Feldmann
Journal of Autoimmunity 1989
T–Cell Activation in Health and Disease
J Timsit, W Savino, C Boitard, JF Bach
T–Cell Activation in Health and Disease 1989
Molecular mechanisms involved in human autoimmune diseases: relevance of chronic antigen presentation. Class II expression and cytokine production
M Feldmann
Immunology 1989

← Previous 1 2 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts